Regulation of Ephrin receptor by inducible ubiquitin ligase SSB
Project/Area Number |
15K21056
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
General medical chemistry
|
Research Institution | Nagoya University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | ユビキチン / EphB2 / 細胞間反発運動 / タンパク質分解 / SPSB4 / Eph / SSB |
Outline of Final Research Achievements |
We identified ephB2 receptor as SSB4 (SPSB4)-interacting protein. SPSB4 is a functionally unknown ubiquitin ligase.EphB2 is known to act as oncogene or tumuor suppressor depending on the cell type. We showed that SPSB4 destabilized EphB2 cytoplasmic domain. Next, we analyzed cell repulsive responses by co-culturing ephrin B2-expressing cells and EphB2-expressing cells.As a result, SPSB4 knock down enhanced cell repulsive responses and SPSB4 was shown to prevent EphB2 signaling pathway.
|
Report
(4 results)
Research Products
(14 results)
-
[Journal Article] Ubiquitin ligase SPSB4 diminishes cell repulsive responses mediated by EphB2.2017
Author(s)
1.Okumura, F., Joo-Okumura, A., Obara, K., Petersen, A., Nishikimi, A., Fukui, Y., Nakatsukasa, K., and Kamura, T
-
Journal Title
Mol Biol Cell
Volume: 28
Issue: 24
Pages: 3532-3541
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Parallel regulation of VHL disease by pVHL-mediated degradation of B-Myb and HIF-alpha2016
Author(s)
Okumura, F., Uematsu, K., Byrne, S.D., Hirano, M., Okumura, A. J., Nishikimi, A., Shuin, T., Fukui, Y., Nakatsukasa, K. & Kamura, T.
-
Journal Title
Mol. Cell. Biol.
Volume: N/A
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] The ubiquitin ligase SCFUcc1 acts as a metabolic switch for the glyoxylate cycle.2015
Author(s)
Nakatsukasa, K., Nishimura, T., Byrne, D., Okamoto, M., Takahashi-Nakaguchi, A., Chibana, H., Okumura, F., Kamura, T.
-
Journal Title
Molecular Cell
Volume: 59
Issue: 1
Pages: 22-34
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-